Literature DB >> 25575722

[Modern diagnostics of cystic liver lesions and hemangiomas].

S Pötter-Lang1, G Brancatelli, N Bastati-Huber, A Ba-Ssalamah.   

Abstract

CLINICAL ISSUE: Cystic liver lesions incorporate a broad heterogeneous group of mostly benign but also malignant abnormalities. The radiological aim is the non-invasive diagnosis with the use of different imaging modalities to determine the type of lesion. STANDARD RADIOLOGICAL
METHODS: The common generally asymptomatic incidental findings of cystic lesions on ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI) must be classified on the basis of specific imaging features. Such a differentiation is essential because the clinical consequences and the appropriate therapy can vary depending on the underlying pathology. Due to the morphological overlap of many cystic lesions, conventional radiological methods are often insufficient. METHODICAL INNOVATIONS: The huge advances in cross-sectional imaging (multidetector CT, MRI with special sequences and different contrast agents and MR cholangiopancreatography) in combination with the clinical history usually enable a non-invasive diagnosis. Pathognomonic morphological and hemodynamic lesion features, as well as a knowledge of the pathomechanisms, help to differentiate this broad spectrum of entities. ACHIEVEMENTS: In this article the different entities of cystic liver lesions, together with the appropriate diagnostic method for detection and distinction and including their strengths and limitations, are demonstrated. PRACTICAL RECOMMENDATIONS: A well-founded knowledge about the development of various cystic liver lesions and the suitable choice of imaging method facilitate a non-invasive diagnosis.

Entities:  

Mesh:

Year:  2015        PMID: 25575722     DOI: 10.1007/s00117-014-2703-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  32 in total

1.  Best cases from the AFIP: giant cavernous hemangioma.

Authors:  Prasanth M Prasanna; Scott E Fredericks; Steven S Winn; Robert A Christman
Journal:  Radiographics       Date:  2010 Jul-Aug       Impact factor: 5.333

2.  MR imaging of benign focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Susanne Baroud; Nina Bastati; Aliya Qayyum
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

Review 3.  Cystic lesions of the liver.

Authors:  Behroze Vachha; Maryellen R M Sun; Bettina Siewert; Ronald L Eisenberg
Journal:  AJR Am J Roentgenol       Date:  2011-04       Impact factor: 3.959

4.  Frequency of benign hepatic lesions incidentally detected with contrast-enhanced thin-section portal venous phase spiral CT.

Authors:  M Völk; M Strotzer; M Lenhart; J Techert; J Seitz; S Feuerbach
Journal:  Acta Radiol       Date:  2001-03       Impact factor: 1.990

5.  Cystic focal liver lesions in the adult: differential CT and MR imaging features.

Authors:  K J Mortelé; P R Ros
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

Review 6.  Congenital cystic lesions of the biliary tree.

Authors:  Inês Santiago; Rui Loureiro; Luis Curvo-Semedo; Cristina Marques; Francisco Tardáguila; Celso Matos; Filipe Caseiro-Alves
Journal:  AJR Am J Roentgenol       Date:  2012-04       Impact factor: 3.959

7.  The prevalence of simple renal and hepatic cysts detected by spiral computed tomography.

Authors:  Z I Carrim; J T Murchison
Journal:  Clin Radiol       Date:  2003-08       Impact factor: 2.350

8.  The amazing universe of hepatic microstructure.

Authors:  Valeer J Desmet
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

9.  Multiple biliary hamartomas: magnetic resonance features with histopathologic correlation.

Authors:  Carla Tohmé-Noun; Dominique Cazals; Roger Noun; Lina Menassa; Dominique Valla; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2007-10-13       Impact factor: 5.315

Review 10.  Development of the bile ducts: essentials for the clinical hepatologist.

Authors:  Mario Strazzabosco; Luca Fabris
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.